Novel human anti-claudin 1 mAbs inhibit hepatitis C virus infection and may synergize with anti-SRB1 mAb
Rolando Paciello(CEINGE Biotecnologie Avanzate Franco Salvatore (Italy)), Claudia De Lorenzo(Istituto Nazionale di Fisica Nucleare, Sezione di Napoli), Emanuele Sasso(CEINGE Biotecnologie Avanzate Franco Salvatore (Italy)), C. Patrick McClure(University of Nottingham), Alfredo Nicosia(Ospedale Antonio Cardarelli), Gennaro Riccio(Sapienza University of Rome), Jonathan K. Ball(University of Nottingham), Nicola Zambrano(University of Naples Federico II), Riccardo Cortese(Sigma Tau (Italy)), Richard A. Urbanowicz(Nottingham University Hospitals NHS Trust)
Cited by 16
Related Papers
Fish Waste: From Problem to Valuable Resource
|Marine Drugs|2021|568
MAIT cells are activated during human viral infections
|Nature Communications|2016|526
Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man
|Science Translational Medicine|2012|401
Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge
|Nature Medicine|2014|352
Chimpanzee Adenovirus Vector Ebola Vaccine
|New England Journal of Medicine|2014|284